Literature DB >> 30712783

ESPEN guideline on clinical nutrition in liver disease.

Mathias Plauth1, William Bernal2, Srinivasan Dasarathy3, Manuela Merli4, Lindsay D Plank5, Tatjana Schütz6, Stephan C Bischoff7.   

Abstract

This update of evidence-based guidelines (GL) aims to translate current evidence and expert opinion into recommendations for multidisciplinary teams responsible for the optimal nutritional and metabolic management of adult patients with liver disease. The GL was commissioned and financially supported by ESPEN. Members of the guideline group were selected by ESPEN. We searched for meta-analyses, systematic reviews and single clinical trials based on clinical questions according to the PICO format. The evidence was evaluated and used to develop clinical recommendations implementing the SIGN method. A total of 85 recommendations were made for the nutritional and metabolic management of patients with acute liver failure, severe alcoholic steatohepatitis, non-alcoholic fatty liver disease, liver cirrhosis, liver surgery and transplantation as well as nutrition associated liver injury distinct from fatty liver disease. The recommendations are preceded by statements covering current knowledge of the underlying pathophysiology and pathobiochemistry as well as pertinent methods for the assessment of nutritional status and body composition.
Copyright © 2019 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Acute liver failure; Alcoholic steatohepatitis; Cirrhosis; Fatty liver disease; Sarcopenia; Transplantation

Mesh:

Year:  2019        PMID: 30712783      PMCID: PMC6686849          DOI: 10.1016/j.clnu.2018.12.022

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  526 in total

1.  Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.

Authors:  Jennifer C Lai; Jennifer L Dodge; Saunak Sen; Kenneth Covinsky; Sandy Feng
Journal:  Hepatology       Date:  2015-12-16       Impact factor: 17.425

2.  Successful treatment of parenteral nutrition-associated liver disease in an adult by use of a fish oil-based lipid source.

Authors:  Esra Venecourt-Jackson; Simon J Hill; Russell S Walmsley
Journal:  Nutrition       Date:  2012-11-07       Impact factor: 4.008

3.  Relation between liver fat content and the rate of VLDL apolipoprotein B-100 synthesis in children with protein-energy malnutrition.

Authors:  Asha Badaloo; Marvin Reid; Deanne Soares; Terrence Forrester; Farook Jahoor
Journal:  Am J Clin Nutr       Date:  2005-05       Impact factor: 7.045

4.  Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation.

Authors:  R G Sawyer; S J Pelletier; T L Pruett
Journal:  Clin Transplant       Date:  1999-02       Impact factor: 2.863

5.  Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real-life cross-sectional study.

Authors:  Filippo Morando; Silvia Rosi; Elisabetta Gola; Mariateresa Nardi; Salvatore Piano; Silvano Fasolato; Marialuisa Stanco; Marta Cavallin; Antonietta Romano; Antonietta Sticca; Lorenza Caregaro; Angelo Gatta; Paolo Angeli
Journal:  Liver Int       Date:  2014-05-21       Impact factor: 5.828

6.  Pre- and perioperative factors affecting infection after living donor liver transplantation.

Authors:  Toshimi Kaido; Akira Mori; Yasuhiro Ogura; Kouhei Ogawa; Koichiro Hata; Atsushi Yoshizawa; Shintaro Yagi; Shinji Uemoto
Journal:  Nutrition       Date:  2012 Nov-Dec       Impact factor: 4.008

7.  Three month intervention with protein and energy rich supplements improve muscle function and quality of life in malnourished patients with non-neoplastic gastrointestinal disease--a randomized controlled trial.

Authors:  Kristina Norman; Henriette Kirchner; Manuela Freudenreich; Johann Ockenga; Herbert Lochs; Matthias Pirlich
Journal:  Clin Nutr       Date:  2007-10-25       Impact factor: 7.324

8.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

Authors:  Erik Kirk; Dominic N Reeds; Brian N Finck; S Mitra Mayurranjan; Mitra S Mayurranjan; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

9.  Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.

Authors:  J Wahren; J Denis; P Desurmont; L S Eriksson; J M Escoffier; A P Gauthier; L Hagenfeldt; H Michel; P Opolon; J C Paris; M Veyrac
Journal:  Hepatology       Date:  1983 Jul-Aug       Impact factor: 17.425

10.  A Model to Identify Sarcopenia in Patients With Cirrhosis.

Authors:  Puneeta Tandon; Gavin Low; Marina Mourtzakis; Laura Zenith; Robert P Myers; Juan G Abraldes; Abdel Aziz M Shaheen; Hina Qamar; Nadia Mansoor; Michelle Carbonneau; Kathleen Ismond; Sumeer Mann; Alshimaa Alaboudy; Mang Ma
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-14       Impact factor: 11.382

View more
  85 in total

1.  Current Management of Alcohol-Associated Liver Disease.

Authors:  Faisal A Siddiqi; Krishna C Sajja; Nyan L Latt
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-11

Review 2.  Nutritional Intervention in Chronic Liver Failure.

Authors:  Mathias Plauth
Journal:  Visc Med       Date:  2019-08-21

3.  Skeletal muscle loss phenotype in cirrhosis: A nationwide analysis of hospitalized patients.

Authors:  Adil Vural; Amy Attaway; Nicole Welch; Joe Zein; Srinivasan Dasarathy
Journal:  Clin Nutr       Date:  2020-04-03       Impact factor: 7.324

Review 4.  The knowns and unknowns of treatment for alcoholic hepatitis.

Authors:  Tejasav S Sehrawat; Mengfei Liu; Vijay H Shah
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05

Review 5.  Outpatient management of alcohol-related liver disease.

Authors:  Douglas A Simonetto; Vijay H Shah; Patrick S Kamath
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-05

Review 6.  Sarcopenia in chronic liver disease: mechanisms and countermeasures.

Authors:  Sophie L Allen; Jonathan I Quinlan; Amritpal Dhaliwal; Matthew J Armstrong; Ahmed M Elsharkawy; Carolyn A Greig; Janet M Lord; Gareth G Lavery; Leigh Breen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-25       Impact factor: 4.052

Review 7.  Sarcopenia in cirrhosis: A practical overview.

Authors:  Amritpal Dhaliwal; Matthew J Armstrong
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

8.  β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.

Authors:  Jacob T Mey; Melissa L Erickson; Christopher L Axelrod; William T King; Chris A Flask; Arthur J McCullough; John P Kirwan
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-05-12       Impact factor: 4.310

Review 9.  Nutrition in Chronic Liver Disease.

Authors:  Yala Kirthi Reddy; Benedict Maliakkal; Uchenna Agbim
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

Review 10.  [Confusion about the effects of omega-3 fatty acids : Contemplation of study data taking the omega-3 index into consideration].

Authors:  C von Schacky
Journal:  Internist (Berl)       Date:  2019-12       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.